Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Chongcao (参七虫草胶囊) is a traditional Chinese medicine capsule formulation that includes ingredients such as fermented Cordyceps fungus powder and Panax notoginseng (Sanqi). It is used primarily for its effects in invigorating qi, nourishing yin, promoting blood circulation, and potentially modulating immune and inflammatory responses. Clinical trials have been conducted to evaluate its efficacy in treating interstitial lung disease (ILD), focusing on inflammation modulation and gene expression related to cell death pathways. The formulation aims at improving symptoms related to lung and kidney deficiencies, fatigue relief, and enhancing physical strength. Its mechanism of action involves multi-target effects typical of herbal combinations but specific molecular targets are not well defined in the literature available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenqi Chongcao.